Welcome to Crene Biotechnology!

+86-576-88205808

Product :

ACH-0141625 Sovaprevir

ACH-0141625 Sovaprevir 1001667-23-7
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:ACH-0141625 Sovaprevir Purity:98% min
CAS NO:1001667-23-7 Solubility:Soluble in DMSO
Molecular Formula:C43H53N5O8S Package:Package according to customer requirements
Molecular Weight:799.975 Storage:Store at -20℃
Quality control
Remarks

Sovaprevir is a nonstructural 3 (NS3) protease inhibitor potentially for the treatment of HCV infection.

 

Synonyms:

(2S,4R)-N-((1R,2S)-1-((Cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl)-1-((2S)-3,3-dimethyl-2-(2-oxo-2-(piperidin-1-yl)ethyl)butanoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide;

(2S,4R)-1-((S)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(7-methoxy-2-phenylquinolin-4-yloxy)pyrrolidine-2-carboxamide;

References

1: De Clercq E. Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochem Pharmacol. 2014 Jun 15;89(4):441-52. doi: 10.1016/j.bcp.2014.04.005. PubMed PMID: 24735613.

2: Vere Hodge RA. Meeting report: 26th International Conference on Antiviral Research. Antiviral Res. 2013 Oct;100(1):276-85. doi: 10.1016/j.antiviral.2013.08.006. PubMed PMID: 23973733.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China